Researchers found that among cancer patients getting immunotherapy, those who got an mRNA Covid vaccine within 100 days ...

An analysis of patient records suggests that mRNA covid-19 vaccines boost the immune response to cancerous tumours when given ...

Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice ...

RNA COVID-19 vaccines — originally developed to protect against the coronavirus — may be providing an additional, unexpected health advantage.

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy ...

An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...

BERLIN, OCTOBER 19, 2025 ― Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were ...

A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new approach to COVID vaccines: using mRNA to let the body assemble its own ...

Moderna, Inc. remains under pressure in 2025, despite recent next-gen COVID vaccine approval & cancer vaccine trial. Learn ...

A groundbreaking study reveals that cancer patients who received a COVID-19 mRNA vaccine within 100 days of starting ...

A vaccine originally designed to protect against Covid-19 has shown unexpected promise in helping the immune system fight ...

Scientists are designing mRNA vaccines to produce virus-like nanoparticles, which should lead to a more robust immune ...